Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125584423 | 12558442 | 3 | F | 20160820 | 20160714 | 20160902 | EXP | JP-TEVA-675658ISR | TEVA | SHIGA Y, KANAYA Y, KONO R, TAKESHIMA S, SHIMOE Y, KURIYAMA M. DEMENTIA WITH LEWY BODIES PRESENTING MARKED TONGUE PROTRUSION AND BITE DUE TO LINGUAL DYSTONIA: A CASE REPORT.CLINICAL NEUROLOGY. 2016; 56(6):418-423 | 53.00 | YR | F | Y | 0.00000 | 20160902 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125584423 | 12558442 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | 5-10MG | Y | 76000 | ||||||||||
| 125584423 | 12558442 | 2 | SS | QUETIAPINE. | QUETIAPINE | 1 | Y | 77745 | 75 | MG | |||||||||
| 125584423 | 12558442 | 3 | SS | ROTIGOTINE | ROTIGOTINE | 1 | Y | 0 | TRANSDERMAL PATCH | ||||||||||
| 125584423 | 12558442 | 4 | SS | ROPINIROLE. | ROPINIROLE | 1 | 1MG TO 6 MG | Y | 0 | 1 | MG | TABLET | |||||||
| 125584423 | 12558442 | 5 | I | LEVODOPA AND CARBIDOPA | CARBIDOPALEVODOPA | 1 | 0 | 100 | MG | ||||||||||
| 125584423 | 12558442 | 6 | I | LEVODOPA AND CARBIDOPA | CARBIDOPALEVODOPA | 1 | INCEASED TO 200-300MG | 0 | |||||||||||
| 125584423 | 12558442 | 7 | I | LEVODOPA AND CARBIDOPA | CARBIDOPALEVODOPA | 1 | 0 | 600 | MG | ||||||||||
| 125584423 | 12558442 | 8 | SS | RISPERIDONE. | RISPERIDONE | 1 | Y | 0 | 2 | MG | |||||||||
| 125584423 | 12558442 | 9 | C | BIPERIDEN | BIPERIDEN | 1 | 0 | 2 | MG | ||||||||||
| 125584423 | 12558442 | 10 | C | BIPERIDEN | BIPERIDEN | 1 | 0 | 3 | MG | ||||||||||
| 125584423 | 12558442 | 11 | C | BIPERIDEN | BIPERIDEN | 1 | 0 | 6 | MG | ||||||||||
| 125584423 | 12558442 | 12 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | ||||||||||||
| 125584423 | 12558442 | 13 | C | Tiapride hydrochloride | TIAPRIDE HYDROCHLORIDE | 1 | 50-150 MG | 0 | |||||||||||
| 125584423 | 12558442 | 14 | C | Perospirone hydrochloride | PEROSPIRONE HYDROCHLORIDE | 1 | 8-16 MG | 0 | |||||||||||
| 125584423 | 12558442 | 15 | C | BROTIZOLAM | BROTIZOLAM | 1 | 0 | .25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125584423 | 12558442 | 3 | Dementia with Lewy bodies |
| 125584423 | 12558442 | 4 | Dementia with Lewy bodies |
| 125584423 | 12558442 | 5 | Dementia with Lewy bodies |
| 125584423 | 12558442 | 9 | Parkinson's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125584423 | 12558442 | HO |
| 125584423 | 12558442 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125584423 | 12558442 | Altered state of consciousness | |
| 125584423 | 12558442 | Condition aggravated | |
| 125584423 | 12558442 | Drug hypersensitivity | |
| 125584423 | 12558442 | Drug interaction | |
| 125584423 | 12558442 | Dyskinesia | |
| 125584423 | 12558442 | Oromandibular dystonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125584423 | 12558442 | 3 | 2014 | 0 | ||
| 125584423 | 12558442 | 4 | 201411 | 0 | ||
| 125584423 | 12558442 | 7 | 201405 | 0 | ||
| 125584423 | 12558442 | 10 | 2013 | 0 | ||
| 125584423 | 12558442 | 11 | 2013 | 0 | ||
| 125584423 | 12558442 | 13 | 2013 | 0 | ||
| 125584423 | 12558442 | 14 | 2013 | 0 |